Back to Journals » Journal of Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma

COPE logo
ISSN: 2253-5969

Journal Articles:

- 1,026 records -

A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study

Zhang C, Xie S, Wang C, Ren T, Zhong X, Zhang Y, Li S, Wu W, Sun Y, Xie C

Journal of Hepatocellular Carcinoma 2026, 13:609066

Published Date: 12 May 2026

USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1

Jiang H, Huang L, Chen J, Jiang Z, Niu W, Wu J, Qiao Z, Pan Y, Jiang X

Journal of Hepatocellular Carcinoma 2026, 13:585217

Published Date: 12 May 2026

Stromal ACTA2 Counteracts TCDD-Induced Hepatocarcinogenesis via Suppression of the PI3K–AKT–mTOR Pathway

He R, Yang Z, Zhang W, Ren Y, Li S, Zhan S, Wang C, Zhang Z

Journal of Hepatocellular Carcinoma 2026, 13:586916

Published Date: 10 May 2026

Dosimetric Impact and Correction of Lipiodol Deposition on Photon-Beam Radiotherapy for Hepatocellular Carcinoma Using a Novel Simulation Model

Guo C, Li M, Zhai Y, Sun W, Zhang X, Yan D, Zhang W, Cao Y, Wang Z, Zhang K, Feng X, Wang S, Tang Y, Li YX, Men K, Chen B

Journal of Hepatocellular Carcinoma 2026, 13:593372

Published Date: 9 May 2026

ADAM12 Stabilizes EIF3B to Promote Glycolysis and Tumor Progression in Hepatocellular Carcinoma

Wu S, Zhu Y, Xia Y, Wu S, Lu C

Journal of Hepatocellular Carcinoma 2026, 13:560478

Published Date: 6 May 2026

GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway

He J, Kong Y, Wang Y, Fang Q, Wu H, Du K, Luo Y, Tan J, Yin H, Lin H, Li M

Journal of Hepatocellular Carcinoma 2026, 13:581550

Published Date: 6 May 2026

Metastatic Fibrolamellar Hepatocellular Carcinoma in a Young Adult: A Case Report and Narrative Review

El Darzi R, Ashy C, Khrayzat A, Chahine S, Tawil A, Temraz S

Journal of Hepatocellular Carcinoma 2026, 13:597439

Published Date: 6 May 2026

Preoperative Prediction of TACE Refractoriness in Hepatocellular Carcinoma Using CT-Based Radiomics Model

Yang L, Liu D, Yang S, Chen J, Wen G

Journal of Hepatocellular Carcinoma 2026, 13:587246

Published Date: 27 April 2026

A Noninvasive Predictive Model of Portal Hypertension in Patients with HCC Based on Clinical Features and Intra- and Peritumoral Pre-Fusion Radiomic Features

Gao Q, Zhu C, Chen M, Mo S, He Y, Huang K, Liao Y, Liang T, Han C, Peng T

Journal of Hepatocellular Carcinoma 2026, 13:596500

Published Date: 24 April 2026

SEMA4F Regulates the Malignant Phenotype of Hepatocellular Carcinoma Cells Through the PI3K-Akt Pathway

Wang JJ, Xie L, Wang X, Chen XY, Xu X, Zhai PP, Xu ZZ, Chen K

Journal of Hepatocellular Carcinoma 2026, 13:596827

Published Date: 24 April 2026

Impact of Child Pugh B Stage for the Treatment of Advanced HCC

Decraecker M, Bourien H, Blanc JF, Edeline J

Journal of Hepatocellular Carcinoma 2026, 13:579537

Published Date: 23 April 2026

Trans-Arterial Chemoembolization Combined with Microwave Ablation versus Microwave Ablation Alone for 3–5 cm Hepatocellular Carcinoma: A Multicenter Retrospective Study

Han D, Li F, Wang G, Niu Y, Wang J, Liang C, Li H, Ju S, Li K, Wang X, Li Y, Niu C, Duan X

Journal of Hepatocellular Carcinoma 2026, 13:581782

Published Date: 22 April 2026

Combination of Traditional Chinese Medicine and Transarterial Chemoembolization for Hepatocellular Carcinoma: A Bibliometric Analysis

Liu X, Zhang K, Wang Z, Zheng Y, Lin L, Wang J, Pan X, Li Y

Journal of Hepatocellular Carcinoma 2026, 13:598236

Published Date: 21 April 2026

Heat Shock Protein 47 as a Novel Predictive and Diagnostic Biomarker for Thrombosis in Hepatocellular Carcinoma

Wang ZG, Peng Y, Wei WY, Liu P, Zhao R, Liu MF

Journal of Hepatocellular Carcinoma 2026, 13:586560

Published Date: 17 April 2026

High-Volume Dilution of Drug-Eluting Beads Reduces Severe Pain After DEB-TACE: A Single-Center Retrospective Study

Gao Z, Li B, Feng B, Sun C, Zang Y, Zhang X, Wang Y, Jia K, Xin Q

Journal of Hepatocellular Carcinoma 2026, 13:602858

Published Date: 15 April 2026

High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients

Dai Y, Pan B, Zhao J, Cai S, Li J, Zou B

Journal of Hepatocellular Carcinoma 2026, 13:600072

Published Date: 14 April 2026

Long-Term Outcome of No-Touch Radiofrequency Ablation for Treating AFP-Positive Small Hepatocellular Carcinoma

Wu G, Huang X, Ou X, Zou M, Xia F, Zhang L, Feng K, Ma K, Wang Q

Journal of Hepatocellular Carcinoma 2026, 13:603375

Published Date: 14 April 2026

C/EBP-β Mediates the Reversal of Sorafenib Resistance by Tunicamycin in Hepatocellular Carcinoma

Pang C, Chen J, Chu M, Chen J, Wang H, Miao H

Journal of Hepatocellular Carcinoma 2026, 13:587037

Published Date: 13 April 2026

The Impact of Spatiotemporal Patterns of Tumor Recurrence on Prognosis in Hepatocellular Carcinoma Patients Undergoing Surgery After Conversion Therapy

Chen Z, Zheng H, Piao M, Zhang L, Sun Y, Zhang K, Zhang J, Liu Y, Xu Y, Lu X

Journal of Hepatocellular Carcinoma 2026, 13:599046

Published Date: 9 April 2026

CENPF Overexpression Induced by HBV Infection Facilitates the G1/S Cell Cycle Transition of Hepatocellular Carcinoma Cells via MYC Pathway

Qi S, Zhou D, Chen S, Ouyang Q, Wu LN, Tang H, Li X, Li Y, Zi H, He P, Wang X, Ou X, Long J, Sun LY, Huang J

Journal of Hepatocellular Carcinoma 2026, 13:580622

Published Date: 1 April 2026

Artificial Intelligence and Radiomics in Primary Liver Cancer Imaging: A Bibliometric and Visualized Analysis

Fu R, Gao C, Lou X, Han Z, He Y, Zheng C, Yu Z, Chang H

Journal of Hepatocellular Carcinoma 2026, 13:578670

Published Date: 1 April 2026

Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience

Khavandi MM, Agahi KN, Lee SS, Kaseb AO, Odisio BC, Abdelsalam ME, Kuban JD, Sheth RA, Avritscher R, Kappadath SC, Mahvash A, Habibollahi P

Journal of Hepatocellular Carcinoma 2026, 13:546213

Published Date: 28 March 2026

Evaluation of Prophylactic EGD versus Beta Blockade in Hepatocellular Carcinoma Patients on Anti-Angiogenic Cancer Treatments

Kontoyiannis PD, Ayerbe C, Chan KH, Soliman S, Machicao V, Rowe JH

Journal of Hepatocellular Carcinoma 2026, 13:575052

Published Date: 27 March 2026

Short- and Long-Term Outcomes of Radiofrequency Ablation for Early Hepatocellular Carcinoma with Liver Dysfunction

Xiao S, Yan Y, Bi H, Tang T, Feng K, Xia F, Tang C, Ma K, Wang Q

Journal of Hepatocellular Carcinoma 2026, 13:587817

Published Date: 26 March 2026

More articles